In our single agent experiments using 7 drugs targeting key cancer processes (e.g., WNT, RAS/RAF/MEK, PI3K/AKT, apoptosis, etc.), we identified responses in specific cellular processes using NetBox (see Methods) analysis that groups proteomic responses into functional modules. This evidence concerns the gene MAP2K7 and cancer.